427 related articles for article (PubMed ID: 19609016)
1. Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors.
Rao NA; van Wolferen ME; Gracanin A; Bhatti SF; Krol M; Holstege FC; Mol JA
J Physiol Pharmacol; 2009 May; 60 Suppl 1():73-84. PubMed ID: 19609016
[TBL] [Abstract][Full Text] [Related]
2. Expression of growth hormone in canine mammary tissue and mammary tumors. Evidence for a potential autocrine/paracrine stimulatory loop.
van Garderen E; de Wit M; Voorhout WF; Rutteman GR; Mol JA; Nederbragt H; Misdorp W
Am J Pathol; 1997 Mar; 150(3):1037-47. PubMed ID: 9060840
[TBL] [Abstract][Full Text] [Related]
3. cDNA microarray profiles of canine mammary tumour cell lines reveal deregulated pathways pertaining to their phenotype.
Rao NA; van Wolferen ME; van den Ham R; van Leenen D; Groot Koerkamp MJ; Holstege FC; Mol JA
Anim Genet; 2008 Aug; 39(4):333-45. PubMed ID: 18462483
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone mRNA in mammary gland tumors of dogs and cats.
Mol JA; van Garderen E; Selman PJ; Wolfswinkel J; Rijinberk A; Rutteman GR
J Clin Invest; 1995 May; 95(5):2028-34. PubMed ID: 7738169
[TBL] [Abstract][Full Text] [Related]
5. Transcriptomic profile of two canine mammary cancer cell lines with different proliferative and anti-apoptotic potential.
Krol M; Pawlowski KM; Skierski J; Rao NA; Hellmen E; Mol JA; Motyl T
J Physiol Pharmacol; 2009 May; 60 Suppl 1():95-106. PubMed ID: 19609018
[TBL] [Abstract][Full Text] [Related]
6. Progestins regulate genes that can elicit both proliferative and antiproliferative effects in breast cancer cells.
Purmonen S; Manninen T; Pennanen P; Ylikomi T
Oncol Rep; 2008 Jun; 19(6):1627-34. PubMed ID: 18497975
[TBL] [Abstract][Full Text] [Related]
7. Different gene-expression profiles for the poorly differentiated carcinoma and the highly differentiated papillary adenocarcinoma in mammary glands support distinct metabolic pathways.
Eilon T; Barash I
BMC Cancer; 2008 Sep; 8():270. PubMed ID: 18811984
[TBL] [Abstract][Full Text] [Related]
8. Mammary steroid metabolizing enzymes in relation to hyperplasia and tumorigenesis in the dog.
Marinelli L; Gabai G; Wolfswinkel J; Mol JA
J Steroid Biochem Mol Biol; 2004 Oct; 92(3):167-73. PubMed ID: 15555910
[TBL] [Abstract][Full Text] [Related]
9. Progestin-induced hypersecretion of growth hormone: an introductory review.
Rijnberk A; Mol JA
J Reprod Fertil Suppl; 1997; 51():335-8. PubMed ID: 9404303
[TBL] [Abstract][Full Text] [Related]
10. Histological and immunohistochemical identification of atypical ductal mammary hyperplasia as a preneoplastic marker in dogs.
Ferreira E; Gobbi H; Saraiva BS; Cassali GD
Vet Pathol; 2012 Mar; 49(2):322-9. PubMed ID: 21282668
[TBL] [Abstract][Full Text] [Related]
11. Comparison of cellular and tissue transcriptional profiles in canine mammary tumor.
Pawlowski KM; Krol M; Majewska A; Badowska-Kozakiewicz A; Mol JA; Malicka E; Motyl T
J Physiol Pharmacol; 2009 May; 60 Suppl 1():85-94. PubMed ID: 19609017
[TBL] [Abstract][Full Text] [Related]
12. Tenascin expression in normal, hyperplastic, dysplastic and neoplastic canine mammary tissues.
Faustino AM; van Garderen E; Schalken JA; Nederbragt H
J Comp Pathol; 2002 Jan; 126(1):1-8. PubMed ID: 11814316
[TBL] [Abstract][Full Text] [Related]
13. Forced activation of Stat5 subjects mammary epithelial cells to DNA damage and preferential induction of the cellular response mechanism during proliferation.
Eilon T; Barash I
J Cell Physiol; 2011 Mar; 226(3):616-26. PubMed ID: 20717961
[TBL] [Abstract][Full Text] [Related]
14. Expression of the oncogene c-erbB-2 in canine mammary cancers and tumor-derived cell lines.
Ahern TE; Bird RC; Bird AE; Wolfe LG
Am J Vet Res; 1996 May; 57(5):693-6. PubMed ID: 8723884
[TBL] [Abstract][Full Text] [Related]
15. The combined expression pattern of BMP2, LTBP4, and DERL1 discriminates malignant from benign canine mammary tumors.
Klopfleisch R; Klose P; Gruber AD
Vet Pathol; 2010 May; 47(3):446-54. PubMed ID: 20375427
[TBL] [Abstract][Full Text] [Related]
16. The relationship between tumour size and expression of prognostic markers in benign and malignant canine mammary tumours.
Ferreira E; Bertagnolli AC; Cavalcanti MF; Schmitt FC; Cassali GD
Vet Comp Oncol; 2009 Dec; 7(4):230-5. PubMed ID: 19891693
[TBL] [Abstract][Full Text] [Related]
17. Bovine mammary gene expression profiling using a cDNA microarray enhanced for mammary-specific transcripts.
Suchyta SP; Sipkovsky S; Halgren RG; Kruska R; Elftman M; Weber-Nielsen M; Vandehaar MJ; Xiao L; Tempelman RJ; Coussens PM
Physiol Genomics; 2003 Dec; 16(1):8-18. PubMed ID: 14559974
[TBL] [Abstract][Full Text] [Related]
18. Secreted frizzled-related protein 2 (SFRP2) is highly expressed in canine mammary gland tumors but not in normal mammary glands.
Lee JL; Chang CJ; Wu SY; Sargan DR; Lin CT
Breast Cancer Res Treat; 2004 Mar; 84(2):139-49. PubMed ID: 14999144
[TBL] [Abstract][Full Text] [Related]
19. Role of progestin-induced mammary-derived growth hormone in the pathogenesis of cystic endometrial hyperplasia in the bitch.
Bhatti SF; Rao NA; Okkens AC; Mol JA; Duchateau L; Ducatelle R; van den Ingh TS; Tshamala M; Van Ham LM; Coryn M; Rijnberk A; Kooistra HS
Domest Anim Endocrinol; 2007 Oct; 33(3):294-312. PubMed ID: 16956744
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of progesterone and cellular proliferation in canine mammary tumours.
Thuróczy J; Reisvaag GJ; Perge E; Tibold A; Szilágyi J; Balogh L
J Comp Pathol; 2007; 137(2-3):122-9. PubMed ID: 17645888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
